OTC Healthcare in Croatia published by Euromonitor International in April, 2009. This report consists of Tables 88 and the price starts from US $ 2400.
Abstract
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive
environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products;
Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies;
Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated
skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans;
Vitamins and dietary supplements; Wound treatments
Executive summary
Growth continues backed by extensive advertising
The growth trend continued in 2008, with current value growth growing at a
faster rate than the review period CAGR. Higher growth was partly driven by
inflation rate in Croatia. The advertising of OTC Healthcare products was
ubiquitous. Leading players such as Pliva dd and GlaxoSmithKline doo were the
most active advertisers. Other major players such as Bayer Pharma doo, Belupo
lijekovi i kozmetika dd
or Krka-Farma doo. Advertising campaigns boosted the awareness of OTC
alternatives, and chemists/pharmacies in Croatia enjoyed positive turnover in
2008.
Customers demand faster and stronger acting products
Modern lifestyles are increasingly hectic and the Croatian working population
is more overwhelmed by responsibilities and duties than ever before. It has
even become common for an employee to claim that he/she is ill and under heavy
medication, yet still work all day. The public health system is very
inefficient and time-consuming, therefore urban consumers tend to put off
visiting their doctor for as long as possible. OTC Healthcare offers
convenient and quick alternatives. For example, fears of stress and obesity
are gaining importance in Croatia, thereby creating the demand for calming and
also slimming products.
Domestic player retains leading position
The domestic manufacturer Pliva dd was the leading player in 2008. The company
was also the main issue concerning the competitive landscape in OTC Healthcare
in Croatia. Pliva, which was purchased by Barr Pharmaceuticals Inc,
experienced another change in ownership in 2008, as Teva Pharmaceutical
Industries Ltd acquired Barr in July 2008. The bleak global economic outlook
also affected the company, making unpopular lay-offs necessary in Pliva' s
Croatian, Polish and Czech factories.
The liberalisation of distribution is on the way
The dominance of OTC Healthcare by chemists/pharmacies softened in 2008. DM-
Drogerie Markt doo' s pioneering effort to open a special OTC Healthcare
department was quickly followed by Atlantic Grupa dd, which has ambitious
plans to create a network of parapharmacies all over Croatia. These
preparations are in full motion, which means that the forecast period should
witness fierce competition between pharmacies and drugstores.
Ambitious development plans continue despite economic slowdown
Although the global economic slowdown is very likely to affect OTC Healthcare
sales in Croatia in the short term, manufacturers are confident about sales
growth over the forecast period. The economic downturn came at the exact
moment that big retailers decided to grab a slice of the OTC Healthcare cake.
Despite the economic slowdown, this development should lead to increased sales
through innovations and new product launches. The investments in strengthening
the parapharmacies/drugstores distribution channel are expected to prevail,
thereby growing sales.
Table of Contents
- OTC HEALTHCARE IN CROATIA : MARKET INSIGHT
- EXECUTIVE SUMMARY
- Growth continues backed by extensive advertising
- Customers demand faster and stronger acting products
- Domestic player retains leading position
- The liberalisation of distribution is on the way
- Ambitious development plans continue despite economic slowdown
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services
2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- MARKET DATA
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: %
Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth
2008-2013
- APPENDIX
- OTC Registration and Classification
- Vitamins & Dietary Supplements Registration and Classification
- Generics
- Switches
- DEFINITIONS
- Summary 1 Research Sources
- ANALGESICS
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Data
- Table 12 Sales of Analgesics by Subsector: Value 2003-2008
- Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
- Table 14 Herbal vs Standard Topical Analgesics 2003-2008
- Table 15 Analgesics Company Shares by Value 2004-2008
- Table 16 Analgesics Brand Shares by Value 2005-2008
- Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
- Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth
2008-2013
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Data
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: Value 2003-2008
- Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: % Value Growth 2003-2008
- Table 21 Sales of Decongestants by Type: Value 2003-2008
- Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: Value 2003-2008
- Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: % Value Growth 2003-2008
- Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies
2003-2008
- Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by
Value 2004-2008
- Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by
Value 2005-2008
- Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: Value 2008-2013
- Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: % Value Growth 2008-2013
- DIGESTIVE REMEDIES
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Data
- Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
- Table 31 Sales of Digestive Remedies by Subsector: % Value Growth
2003-2008
- Table 32 Herbal vs Standard Digestive Remedies 2003-2008
- Table 33 Digestive Remedies Company Shares by Value 2004-2008
- Table 34 Digestive Remedies Brand Shares by Value 2005-2008
- Table 35 Forecast Sales of Digestive Remedies by Subsector: Value
2008-2013
- Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value
Growth 2008-2013
- MEDICATED SKIN CARE
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Data
- Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
- Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth
2003-2008
- Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
- Table 40 Medicated Skin Care Company Shares by Value 2004-2008
- Table 41 Medicated Skin Care Brand Shares by Value 2005-2008
- Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value
2008-2013
- Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value
Growth 2008-2013
- VITAMINS AND DIETARY SUPPLEMENTS IN CROATIA
- Headlines
- Trends
- Competitive Landscape
- Prospects
- Sector Data
- Table 44 Sales of Vitamins and Dietary Supplements by Subsector: Value
2003-2008
- Table 45 Sales of Vitamins and Dietary Supplements by Subsector: % Value
Growth 2003-2008
- Table 46 Vitamins and Dietary Supplements Company Shares by Value
2004-2008
- Table 47 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
- Table 48 Vitamins Brand Shares by Value 2005-2008
- Table 49 Dietary Supplements Brand Shares by Value 2005-2008
- Table 50 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: Value 2008-2013
- Table 51 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: % Value Growth 2008-2013
- NRT SMOKING CESSATION AIDS
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- SECTOR INDICATORS
- Table 52 Number of Smokers by Gender 2003-2008
- Sector Data
- Table 53 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
- Table 54 Sales of Smoking Cessation Aids by Subsector: % Value Growth
2003-2008
- Table 55 Smoking Cessation Aids Company Shares by Value 2004-2008
- Table 56 Smoking Cessation Aids Brand Shares by Value 2005-2008
- Table 57 Forecast Sales of Smoking Cessation Aids by Subsector: Value
2008-2013
- Table 58 Forecast Sales of Smoking Cessation Aids by Subsector: % Value
Growth 2008-2013
- EYE CARE
- Headlines
- Sector Data
- Table 59 Sales of Eye Care by Subsector: Value 2003-2008
- Table 60 Sales of Eye Care by Subsector: % Value Growth 2003-2008
- Table 61 Eye Care Company Shares by Value 2004-2008
- Table 62 Eye Care Brand Shares by Value 2005-2008
- Table 63 Forecast Sales of Eye Care by Subsector: Value 2008-2013
- Table 64 Forecast Sales of Eye Care by Subsector: % Value Growth
2008-2013
- WOUND TREATMENTS
- Sector Data
- Table 65 Sales of Wound Treatments by Subsector: Value 2003-2008
- Table 66 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
- Table 67 Wound Treatments Company Shares by Value 2004-2008
- Table 68 Wound Treatments Brand Shares by Value 2005-2008
- Table 69 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
- Table 70 Forecast Sales of Wound Treatments by Subsector: % Value Growth
2008-2013
- EAR CARE
- Headlines
- Sector Data
- Table 71 Sales of Ear Care: Value 2003-2008
- Table 72 Sales of Ear Care: % Value Growth 2003-2008
- Table 73 Ear Care Company Shares by Value 2004-2008
- Table 74 Ear Care Brand Shares by Value 2005-2008
- Table 75 Forecast Sales of Ear Care: Value 2008-2013
- Table 76 Forecast Sales of Ear Care: % Value Growth 2008-2013
- ADULT MOUTH CARE
- Headlines
- Sector Data
- Table 77 Sales of Adult Mouth Care: Value 2003-2008
- Table 78 Sales of Adult Mouth Care: % Value Growth 2003-2008
- Table 79 Adult Mouth Care Company Shares by Value 2004-2008
- Table 80 Adult Mouth Care Brand Shares by Value 2005-2008
- Table 81 Forecast Sales of Adult Mouth Care: Value 2008-2013
- Table 82 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
- CALMING AND SLEEPING PRODUCTS
- Headlines
- Sector Data
- Table 83 Sales of Calming and Sleeping Products: Value 2003-2008
- Table 84 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
- Table 85 Calming and Sleeping Products Company Shares by Value 2004-2008
- Table 86 Calming and Sleeping Products Brand Shares by Value 2005-2008
- Table 87 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
- Table 88 Forecast Sales of Calming and Sleeping Products: % Value Growth
2008-2013
- EMERGENCY CONTRACEPTION
- Headlines
- BELUPO DD
- Strategic Direction
- Key Facts
- Summary 2 Belupo dd: Key Facts
- Summary 3 Belupo dd: Operational Indicators
- Company Background
- Production
- Summary 4 Belupo dd: Production Statistics 2008
- Competitive Positioning
- Summary 5 Belupo dd: Competitive Position 2008
- JADRAN GALENSKI LABORATORIJ
- Strategic Direction
- Key Facts
- Summary 6 Jadran Galenski Laboratorij: Key Facts
- Summary 7 Jadran Galenski Laboratorij: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Summary 8 Jadran Galenski Laboratorij: Competitive Position 2007
- PLIVA DD
- Strategic Direction
- Key Facts
- Summary 9 Pliva dd: Key Facts
- Summary 10 Pliva dd: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Summary 11 Pliva dd: Competitive Position 2008
